SoftBank-Backed Chinese Cancer Detection Products Developer Gets $66M Fresh Funds

New Horizon Health, a Chinese company that primarily develops cancer detection and screening products, unveiled on Friday that it has secured US$66 million in a series C round of financing led by Hong Kong-based private equity firm VMS Investment Group.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets